Price (delayed)
$146.28
Market cap
$258.69B
P/E Ratio
19.43
Dividend/share
$5.71
EPS
$7.53
Enterprise value
$316.47B
AbbVie is an American publicly traded biopharmaceutical company founded in 2013. It originated as a spin-off of Abbott Laboratories. On October 19, 2011, Abbott Laboratories announced its plan to separate
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.